SCHEMBL6124252

SCHEMBL6124252

CC(C)c1ccc2c(c1)CCCN2C(=O)N(C)C

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 2/20 0.61
PDK2 Q15119 2/20 0.61
PDK3 Q15120 2/20 0.61
PDK4 Q16654 2/20 0.61
TP53 P04637 3/20 0.48
HTR2A P28223 1/20 0.46
HTR2C P28335 1/20 0.46
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 4/20 0.46
LMNA P02545 3/20 0.46
TSHR P16473 2/20 0.46
ADRB2 P07550 1/20 0.46
ADRB1 P08588 1/20 0.46
NR3C1 P04150 1/20 0.45
HSD17B10 Q99714 1/20 0.45
IDO1 P14902 2/20 0.43
KCNH2 Q12809 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
NPSR1 Q6W5P4 1/20 0.42
NOTUM Q6P988 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6124270 0.92 HTR2A (0.54) PDK1PDK2PDK3PDK4TP53
SCHEMBL28459583 0.86 PDK1 (0.64) PDK1PDK2PDK3PDK4TP53
SCHEMBL13711475 0.86 PDK1 (0.64) PDK1PDK2PDK3PDK4TP53
SCHEMBL17368396 0.84 PDK1 (0.62) PDK1PDK2PDK3PDK4TP53
SCHEMBL6127792 0.83 KDM4E (0.66) PDK1PDK2PDK3PDK4TP53
SCHEMBL24511819 0.81 PDK1 (0.59) PDK1PDK2PDK3PDK4TP53
SCHEMBL22482270 0.79 PDK1 (0.57) PDK1PDK2PDK3PDK4TP53
SCHEMBL8563605 0.78 NOTUM (0.69) ALDH1A1TSHRSMN1; SMN2NPSR1NOTUM
SCHEMBL6124253 0.77 NOTUM (0.65) PDK1PDK2PDK3PDK4TP53
SCHEMBL14924062 0.76 HTR2A (0.50) PDK1PDK2PDK3PDK4TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8809318-B2 Gamma secretase modulators MERCK SHARP & DOHME CORP. (US) 2014-08-19 US disclosed
US-8487099-B2 Gamma secretase modulators MERCK SHARP & DOHME CORP. (US) 2013-07-16 US disclosed
US-20120129846-A1 GAMMA SECRETASE MODULATORS Merck, Sharp & Dohme, Corp. 2012-05-24 US disclosed
US-20120129846-A1 GAMMA SECRETASE MODULATORS Merck, Sharp & Dohme, Corp. 2012-05-24 US disclosed
US-20120107328-A1 GAMMA SECRETASE MODULATORS MERCK SHARP & DOHME CORP. 2012-05-03 US disclosed
US-20110306593-A1 GAMMA SECRETASE MODULATORS MERCK SHARP & DOHME LLC 2011-12-15 US disclosed
US-20110263529-A1 GAMMA SECRETASE MODULATORS MERCK SHARP & DOHME CORP. 2011-10-27 US disclosed
US-20110263529-A1 GAMMA SECRETASE MODULATORS MERCK SHARP & DOHME CORP. 2011-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120107328-A1 GAMMA SECRETASE MODULATORS BACE1, BACE2, PSEN1 PDK1 2884/4885PDK2 3648/4885PDK3 3954/4885
US-20120129846-A1 GAMMA SECRETASE MODULATORS BACE1, BACE2, PSEN1 PDK1 1705/4885PDK2 3300/4885PDK3 3219/4885
US-20110306593-A1 GAMMA SECRETASE MODULATORS BACE1, BACE2, PSEN1 PDK1 2092/4885PDK2 3451/4885PDK3 3295/4885
US-20110263529-A1 GAMMA SECRETASE MODULATORS BACE1, BACE2, PSEN1 PDK1 1923/4885PDK2 3636/4885PDK3 3406/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.